glp-1 cigna coverage in Employer Plans Could Nearly Double in 2024 Cigna dropping all GLP-1 coverage
Description
SOLIQUA [soh LEE kwa] combines lixisenatide with insulin glargine (Lantus)
Reddy's Generic Semaglutide Reached Canadian Pharmacies May 15 Dr
In November 2025, the Trump Administration announced an upcoming demonstration project that will extend coverage for GLP-1s to people living with obesity and related complications starting later in 2026
A meta-analysis summarized the results of these randomized trials, showing a significant reduction in MACEs, CV death, stroke, myocardial infarction, death from all causes, heart failure, and kidney disease, emphasizing the important glycometabolic effects and extraglycemic actions that would determine a significant clinical benefit in patients with T2DM [40]
While most people report positive effects while on GLP-1s, the experience isnt golden for everyone, says Vij
Mietlicki-Baase EG, Ortinski PI, Rupprecht LE, Olivos DR, Alhadeff AL, Pierce RC, et al
